CEACAM5 and colorectal carcinoma: Recently, a lectin microarray platform demonstrated that CEA from colorectal carcinoma patient tissues have a distinct pattern of glycosylation compared to normal tissue 49 and lately it was identified N-glycan compositions indicative for the presence of outer arm fucose residues such as Lewis antigens 50.